Asia growth: The main reason Nestle could be keen on Mead Johnson acquisition
The financial press is rife with chatter that Nestle is weighing up a bid for US infant formula firm Mead Johnson.
The financial press is rife with chatter that Nestle is weighing up a bid for US infant formula firm Mead Johnson.
The FDA has no objections to Ganeden BC30s GRAS status for use in infant formulas, the company announced this week.